Table of Contents Author Guidelines Submit a Manuscript
Letter to the Editor
International Journal of Hypertension
Volume 2013, Article ID 578578, 10 pages
Clinical Study

Genetic and Adverse Health Outcome Associations with Treatment Resistant Hypertension in GenHAT

1Department of Epidemiology, University of Alabama at Birmingham, RPHB 220E, 1530 3rd Avenue South, Birmingham, AL 55294-0022, USA
2School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX 20186, USA
3Department of Laboratory Medicine and Pathology, University of Minnesota, Mayo Mail Code 609, 420 Delaware Street SE, Minneapolis, MN 55455, USA

Received 25 January 2013; Accepted 18 September 2013

Academic Editor: B. Waeber

Copyright © 2013 Amy I. Lynch et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [10 citations]

The following is the list of published articles that have cited the current article.

  • V Fontana, M R Luizon, and V C Sandrim, “An update on the pharmacogenetics of treating hypertension,” Journal of Human Hypertension, 2014. View at Publisher · View at Google Scholar
  • Vanessa Fontana, Caitrin W. McDonough, Yan Gong, Nihal M. El Rouby, Ana Caroline C. Sa, Kent D. Taylor, Y. -D. Ida Chen, John G. Gums, Arlene B. Chapman, Stephen T. Turner, Carl J. Pepine, Julie A. Johnson, and Rhonda M. Cooper-DeHoff, “Large-Scale Gene-Centric Analysis Identifies Polymorphisms for Resistant Hypertension,” Journal of The American Heart Association, vol. 3, no. 6, 2014. View at Publisher · View at Google Scholar
  • Sreekanth Vemulapalli, Crystal C. Tyson, and Laura P. Svetkey, “Apparent Treatment-Resistant Hypertension and Chronic Kidney Disease: Another Cardiovascular-Renal Syndrome?,” Advances in Chronic Kidney Disease, vol. 21, no. 6, pp. 489–499, 2014. View at Publisher · View at Google Scholar
  • Natalia Ruggeri Barbaro, Vanessa Fontana, and Heitor Moreno, “Angiotensinogen Variants among Resistant Hypertensive Patients,” International Journal of Hypertension, vol. 2014, pp. 1–1, 2014. View at Publisher · View at Google Scholar
  • George Maliha, and Raymond R. Townsend, “An Update on Treatment Options for Drug Resistant Hypertension,” Current Cardiovascular Risk Reports, vol. 8, no. 8, pp. 1–9, 2014. View at Publisher · View at Google Scholar
  • Nihal El Rouby, and Rhonda M. Cooper-DeHoff, “Genetics of Resistant Hypertension: a Novel Pharmacogenomics Phenotype,” Current Hypertension Reports, vol. 17, no. 9, 2015. View at Publisher · View at Google Scholar
  • Merrill F. Elias, and Rachael V. Torres, “Delayed Response to Antihypertension Medication: A Harbinger of Stroke, Heart Failure, and Vascular Disease,” Hypertension, vol. 70, no. 1, pp. 30–31, 2017. View at Publisher · View at Google Scholar
  • Alexandru Burlacu, and Adrian Covic, “Pathophysiological Insights in Resistant Hypertension,” Resistant Hypertension in Chronic Kidney Disease, pp. 89–126, 2017. View at Publisher · View at Google Scholar
  • Robert M. Carey, David A. Calhoun, George L. Bakris, Robert D. Brook, Stacie L. Daugherty, Cheryl R. Dennison-Himmelfarb, Brent M. Egan, John M. Flack, Samuel S. Gidding, Eric Judd, Daniel T. Lackland, Cheryl L. Laffer, Christopher Newton-Cheh, Steven M. Smith, Sandra J. Taler, Stephen C. Textor, Tanya N. Turan, and William B. White, “Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association,” Hypertension, vol. 72, no. 5, 2018. View at Publisher · View at Google Scholar
  • Boon-Peng Hoh, Thuhairah Abdul Rahman, and Khalid Yusoff, “Natural selection and local adaptation of blood pressure regulation and their perspectives on precision medicine in hypertension,” Hereditas, vol. 156, no. 1, 2019. View at Publisher · View at Google Scholar